Long-term Effects of Methadone for Cancer Pain
Status
Conditions
Details and patient eligibility
About
The methadone is an useful opioid for the cancer pain treatment, mostly used in second or last line during the opioid rotation. The Methadone had an anti-MNDA effect, and clinicians agree that the methadone could have an effect in neuropathic cancer pain. During a previous study the investigators find that the pain was still improving after the week 2, but they had only a small number of patients still included at this stage and they cannot conclude.
The investigators decide to follow up systematically all the patients undergoing a methadone treatment for cancer pain, at day 28, to study the hypothesis about the long-term pain improvement.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients with t methadone for cancer pain in opioid rotation
- Able to fill the questionnaire
- Performance status (PS) from 0 to 2
Exclusion criteria
- Patients PS 3
- Unable to sign the informed consent
Trial contacts and locations
Loading...
Central trial contact
Marilene FILBET, Pr Associate
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal